Antwerp's Sightera Biosciences raises €3 million to scale its patient-derived AI drug ...
Sightera is a BioTech company that uses AI to discover and design new medicines, with a current focus on oncology and fibrosis. The company states ...
Read the original at EU-Startups ↗
- Topics
- Healthcare
- Tracked via
- “that uses AI to”